In vivo impact of a 4 bp deletion mutation in the DLX3 gene on bone development

Developmental Biology

Volumn 325, Issue 1, 2009, Pages 129-137

  Choi, S J ^a   Roodman, G D ^b   Feng, J Q ^c   Song, I S ^a   Amin, K ^a   Hart, P S ^d   Wright, J T ^e   Haruyama, N ^f   Hart, T C ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF DENTISTRY   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e University of North   (United States)

^f TOHOKU UNIVERSITY   (Japan)

Author keywords

Bone mineralization; DLX3; Interferon gamma; Osteoclast; Rodent; Transgenic mice

Indexed keywords

FLUOROCHROME; GAMMA INTERFERON; PROTEIN DLX3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; IN VIVO STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PRIORITY JOURNAL;

MUS; MUS MUSCULUS; RODENTIA;

EID: 57849127697     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2008.10.014     Document Type: Article

References (41)

1. Alatalo S.L., Halleen J.M., Hentunen T.A., Mönkkönen J., and Väänänen H.K. Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium. Clin. Chem. 46 (2000) 1751-1754
2. Amento E.P., Bhan A.K., McCullagh K.G., and Krane S.M. Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. J. Clin. Invest. 76 (1985) 837-848
3. Bab I.A., and Einhorn T.A. Regulatory role of osteogenic growth polypeptides in bone formation and hemopoiesis. Crit. Rev. Eukaryot. Gene Expr. 3 (1993) 31-46
4. Bab I., Gazit D., Chorev M., Muhlrad A., Shteyer A., Greenberg Z., Namdar M., and Kahn A. Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. EMBO 11 (1992) 1867-1873
5. Bryan J.T., and Morasso M.I. The DLX3 protein harbors basic residues required for nuclear localization, transcriptional activity and binding to MSX1. J. Cell. Sci. 113 (2000) 4013-4023
6. Choi S.J., Song I.S., Ryu O.H., Choi S.W., Hart P.S., Wu W.W., Shen R.F., and Hart T.C. A 4 bp deletion mutation in DLX3 enhances osteoblastic differentiation and bone formation in vitro. Bone 42 (2008) 162-171
7. Delmas P.D. Biochemical markers of bone turnover. I: Theoretical considerations and clinical use in osteoporosis. Am. J. Med. 95 (1993) 11S-16S
8. Duverger O., Lee D., Hassan M.Q., Chen S.X., Jaisser F., Lian J.B., and Morasso M.I. Molecular consequences of a frameshifted DLX3 mutant leading to Tricho-Dento-Osseous syndrome. J. Biol. Chem. 283 (2008) 20198-20208
9. Ehrlich L.A., Chung H.Y., Ghobrial I., Choi S.J., Morandi F., Colla S., Rizzoli V., Roodman G.D., and Giuliani N. IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma. Blood 106 (2005) 1407-1414
10. Franceschi R.T., and Lyer B.S. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J. Bone Miner. Res. 7 (1992) 235-246
11. Garimella R., Bi X., Camacho N., Sipe J.B., and Anderson H.C. Primary culture of rat growth plate chondrocytes: an in vitro model of growth plate histotype, matrix vesicle biogenesis and mineralization. Bone 34 (2004) 961-970
12. Gori F., Friedman L.G., and Demay M.B. Wdr5, a WD-40 protein, regulates osteoblast differentiation during embryonic bone development. Dev. Biol. 295 (2006) 498-506
13. Haldeman R.J., Cooper L.F., Hart T.C., Phillips C., Boyd C., Lester G.E., and Wright J.T. Increased bone density associated with DLX3 mutation in the Tricho-Dento-Osseous syndrome. Bone 35 (2004) 988-997
14. Hassan M.Q., Javed A., Morasso M.I., Karlin J., Montecino M., van Wijnen A.J., Stein G.S., Stein J.L., and Lian J.B. DLX3 transcriptional regulation of osteoblast differentiation: temporal recruitment of MSX2, DLX3, and DLX5 homeodomain proteins to chromatin of the osteocalcin gene. Mol. Cell. Biol. 24 (2004) 9248-9261
15. Hassan M.Q., Saini S., Gordon J.A.R., van Wijnen A.J., Montecino M., Stein J.L., Stein G.S., and Lian J.B. Molecular switches involving homeodomain proteins, HOXA10 and RUNX2 regulate osteoblastogenesis. Cells Tissues Organs (2008) Aug, 14. [Epub ahead of print]
16. Islam M., Lurie A.G., and Reichenberger E. Clinical features of Tricho-Dento-Osseous syndrome and presentation of three new cases: an addition to clinical heterogeneity. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 100 (2005) 736-742
17. Jiang J., Lichtler A.C., Gronowicz G.A., Adams D.J., Clark S.H., Rosen C.J., and Kream B.E. Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 39 (2006) 494-504
18. Jono S., Peinado C., and Giachelli C.M. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J. Biol. Chem. 275 (2000) 20197-20203
19. Kadono Y., Okada F., Perchonock C., Jang H.D., Lee S.Y., Kim N., and Choi Y. Strength of TRAF6 signaling determines osteoclastogenesis. EMBO 6 (2005) 171-176
20. Kamolmatyakul S., Chen W., and Li Y.P. Interferon-gamma down-regulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation. J. Dent. Res. 80 (2001) 351-355
21. Kanatani N., Fujita T., Fukuyama R., Liu W., Yoshida C.A., Moriishi T., Yamana K., Miyazaki T., Toyosawa S., and Komori T. Cbfbeta regulates Runx2 function isoform-dependently in postnatal bone development. Dev. Biol. 296 (2006) 48-61
22. Karaplis A.C., and Deckelbaum R.A. Role of PTHrP and PTH-1 receptor in endochondral bone development. Front. Biosci. 3 (1998) 795-803
23. Kiviranta R., Morko J., Alatalo S.L., NicAmhlaoibh R., Risteli J., Laitala-Leinonen T., and Vuorio E. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. Bone 36 (2005) 159-172
24. Kula K., Hall K., Hart T., and Wright J.T. Craniofacial morphology of the Tricho-Dento-Osseous syndrome. Clin. Genet. 50 (1996) 446-454
25. Nakamura T., Takeuchi K., Muraoka S., Muneoka K., and Takigawa M. A neurally enriched coronin-like protein, ClipinC, is a novel candidate for an actin cytoskeleton-cortical membrane-linking protein. J. Biol. Chem. 274 (1999) 13322-13327
26. Price J.A., Bowden D.W., Wright J.T., Pettenati M.J., and Hart T.C. Identification of a mutation in DLX3 associated with Tricho-Dento-Osseous (TDO) syndrome. Hum. Mol. Genet. 7 (1998) 563-569
27. Price J.A., Wright J.T., Kula K., Bowden D.W., and Hart T.C. A common DLX3 gene mutation is responsible for Tricho-Dento-Osseous syndrome in Virginia and North Carolina families. J. Med. Genet. 35 (1998) 825-828
28. 1: a novel osteoclast integrin that regulates osteoclast formation and function. J. Bone Miner. Res. 21 (2006) 1657-1665
29. Rho J., Takami M., and Choi Y. Osteoimmunology: interactions of the immune and skeletal systems. Mol. Cells 17 (2004) 1-9
30. Rodan G.A., and Noda M. Gene expression in osteoblastic cells. Crit. Rev. Eukaryot. Gene Exp. 1 (1991) 85-98
31. Schmidt K., Schinke T., Haberland M., Priemel M., Schilling A.F., Mueldner C., Rueger J.M., Sock E., Wegner M., and Amling M. The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation. J. Cell. Biol. 168 (2005) 899-910
32. Smith D.D., Gowen M., and Mundy G.R. Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone cultures. Endocrinology 120 (1987) 2494-2499
33. Sontag W. An automatic microspectrophotometric scanning method for the measurement of bone formation rates in vivo. Calcif. Tissue Int. 32 (1980) 63-68
34. Stanford C.M., Jacobson P.A., Eanes E.D., Lembke L.A., and Midura R.J. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J. Biol. Chem. 270 (1995) 9420-9428
35. Suda T., Jimi E., Nakamura I., and Takahashi N. Role of 1α,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol. 282 (1997) 223-235
36. Takahashi N., Mundy G.R., and Roodman G.D. Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells. J. Immunol. 137 (1986) 3544-3549
37. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., Takaoka A., Yokochi T., Oda H., Tanaka K., Nakamura K., and Taniguchi T. T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature 408 (2000) 600-605
38. Takayanagi H., Kim S., and Taniguchi T. Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res. 4 (2002) S227-S232
39. Walsh M.C., Kim N., Kadono Y., Rho J., Lee S.Y., Lorenzo J., and Choi Y. Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24 (2006) 33-63
40. Weitzmann M.N., and Pacifici R. T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis. Ann. N.Y. Acad. Sci. 1116 (2007) 360-375
41. Wright J.T., Kula K., Hall K., Simmons J.H., and Hart T.C. Analysis of the Tricho-Dento-Osseous syndrome genotype and phenotype. Am. J. Med. Genet. 72 (1997) 197-204